Folly liver, hypertension, and the metabolic syndrome

Diehl, A. M.
July 2004
Gut;Jul2004, Vol. 53 Issue 7, p923
Academic Journal
The prevalence of fatly liver in non-obese non-diabetic hypertensive patients is at least twice that of the general population and may be related to increases in insulin resistance and body weight.


Related Articles

  • Predictive values of metabolic syndrome in children. Vorgučin, Ivana; Naumović, Nada; Vlaški, Jovan; Katanić, Dragan; Konstantinidis, Georgios // Central European Journal of Medicine;Aug2011, Vol. 6 Issue 4, p379 

    Metabolic syndrome is a clinical term encompassing risk factors (obesity, insulin resistance, dyslipidemia and hypertension), which yield an increased risk for the development of diabetes mellitus type 2 and cardiovascular disorders in adolescence. Two sets of criteria for diagnosing metabolic...

  • Insulinoopornośż w cukrzycy typu 1. Uruska, Aleksandra; Araszkiewicz, Aleksandra // Pediatric Endocrinology, Diabetes & Metabolism;2009, Vol. 15 Issue 2, p119 

    Insulin determines glucose transport to the most of cells. Decreased answer of target cells to insulin is called insulin resistance. This phenomenon depends on genetic and environmental factors. The most important risk factor of progression of insulin resistance is style of life created by...

  • Prevalence and Factor Analysis of Metabolic Syndrome in an Urban Korean Population. Oh, Jee-Young; Hong, Young Sun; Sung, Yeon-Ah; Barrett-Connor, Elizabeth // Diabetes Care;Aug2004, Vol. 27 Issue 8, p2027 

    OBJECTIVE — The aim of this study was to explore the prevalence and pattern of the metabolic syndrome and its association with hyperinsulinemia in an urban Korean population of 269 men and 505 women. RESEARCH DESIGN AND METHODS — The National Cholesterol Education Program Adult...

  • Clinical features of nonalcoholic steatohepatitis in Japan: evidence from the literature. Ono, Masafumi; Saibara, Toshiji // Journal of Gastroenterology;Aug2006, Vol. 41 Issue 8, p725 

    Metabolic syndrome, that is, obesity, hypertension, hyperlipidemia, and insulin resistance with hyperinsulinemia, is a new disease entity prevailing worldwide, and nonalcoholic steatohepatitis (NASH) is believed to be a hepatic expression of this syndrome. NASH is characterized by zone...

  • Association of Plasma Retinol-Binding Protein 4, Adiponectin, and High Molecular Weight Adiponectin with Insulin Resistance in Non-Diabetic Hypertensive Patients. Chi Young Shim; Sungha Park; Jung-Sun Kim; Dong Jik Shin; Young-Guk Ko; Seok-Min Kang; Donghoon Choi; Jong-Won Ha; Yangsoo Jang; Namsik Chung // Yonsei Medical Journal;5/1/2010, Vol. 51 Issue 3, p375 

    Purpose: The aim of this study was to determine whether retinol-binding protein 4 (RBP4), adiponectin and high molecular weight (HMW) adiponectin are associated with insulin resistance (IR) and metabolic parameters in non-diabetic hypertensive patients. Also, we sought to compare the predictive...

  • Design and Validation of a Population-Based Definition of the Metabolic Syndrome. Aguilar-Salinas, Carlos A.; Rojas, Rosalba; Gonzalez-Villalpando, Clicerio; Gómez-Pérez, Francisco J.; Mehta, Roopa; Olaiz, Gustavo; Rull, Juan A.; Cox, David R. // Diabetes Care;Nov2006, Vol. 29 Issue 11, p2420 

    OBJECTIVE -- The National Cholesterol Education Program (NCEP) definition of the metabolic syndrome was modified to be described as a continuous variable and adapted to the characteristics of a Hispanic population. RESEARCH DESIGN AND METHODS -- Age/sex population percentiles for every component...

  • You are what you eat: food ingredients and the metabolic syndrome. Prakash Apte, Shireesh // Journal of Excipients & Food Chemicals;Jun2012, Vol. 3 Issue 2, p26 

    The author reflects on the role of food ingredients and metabolic syndrome in human health. The author is critical on the attributes of the proliferation of the metabolic syndrome and the components of metabolic syndrome including hypertension, obesity, dyslipidaemia and insulin resistance....

  • Adiponectin and Insulin Sensitivity in Primary Aldosteronism. Fallo, Francesco; Della Mea, Paolo; Sonino, Nicoletta; Bertello, Chiara; Ermani, Mario; Vettor, Roberto; Veglio, Franco; Mulatero, Paolo // American Journal of Hypertension;Aug2007, Vol. 20 Issue 8, p855 

    Background: A high prevalence of metabolic syndrome has been reported in primary aldosteronism. Low levels of adiponectin, an adipokine with insulin-sensitizing properties, are considered a hallmark of the metabolic syndrome. We evaluated the relationship between adiponectin and insulin...

  • Prevalence of the metabolic syndrome in a rural population in Ghana. Gyakobo, Mawuli; Amoah, Albert G. B.; Martey-Marbell, De-Anne; Snow, Rachel C. // BMC Endocrine Disorders;2012, Vol. 12 Issue 1, p25 

    Background: The Metabolic syndrome (MS) which is a constellation of cardiometabolic risk factors including dyslipidaemia, hypertension, hyperglycaemia, central obesity, and endothelial dysfunction was hitherto relatively uncommon among Africans south of the Sahara. This study seeks to determine...


Read the Article


Sign out of this library

Other Topics